Clinical trial
Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful…
NCT00001955 · National Institute of Dental and Craniofacial Research (NIDCR), NIH · Completed
Key facts
| NCT number | NCT00001955 |
|---|---|
| Title | Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions) |
| Official title | The Role of Cytokines as Inflammatory Mediators in Painful Temporomandibular Joints |
| Lead sponsor | National Institute of Dental and Craniofacial Research (NIDCR), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Temporomandibular Joint Disorder |
| Intervention type | Drug |
| Interventions | Etanercept, Celecoxib |
| Enrollment | 150 |
| Start date | Dec 1, 1999 |
| Completion | Feb 1, 2004 |
| First posted | Jan 19, 2000 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: